Skip to main content
Predictmedix AI Inc. logo

Predictmedix AI Inc. — Investor Relations & Filings

Ticker · PMED ISIN · CA74040N1069 LEI · 254900EU3WH68HQM4J21 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 190 across all filing types
Latest filing 2026-04-27 Regulatory Filings
Country CA Canada
Listing CSE PMED

About Predictmedix AI Inc.

https://predictmedix.com/

Predictmedix AI Inc. is a Life Sciences technology company focused on developing disruptive artificial intelligence tools for health screening and impairment testing. The company's primary offering, the SmartHealth AI Stations, provides quick, noninvasive, and no-contact solutions for assessing individual readiness. Utilizing multispectral cameras and sensors, these AI-powered stations are designed to detect indicators of impairment, extreme fatigue, and infectious diseases. The technology is primarily targeted at improving workplace health and safety and enhancing protection in public environments. Predictmedix also develops specialized AI tools for healthcare applications, including the detection of PTSD implemented in hospital units. A key feature of their technology is the commitment to accurate detection while ensuring user privacy. Furthermore, the company is developing an adaptive-AI engine intended to simulate, optimize, and predict outcomes across multi-site clinical trials.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 87% confidence The document is a press release announcing commercialization and outreach activities for QScreen AI’s new platform. It contains forward‐looking statements and standard disclaimer language but does not present financial results (so it is not an Earnings Release or Interim/Annual Report), does not announce board changes, financing terms, dividends, share transactions, or any formal regulatory vote results. It is not a presentation deck, audit, or legal proceeding update. Therefore it does not fit any specialized category and defaults to the general “Regulatory Filings” fallback category (RNS).
2026-04-27 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a corporate name change from Predictmedix AI Inc. to QScreen AI Inc. It details the effective date of the name change, the new trading symbol, and confirms that there are no changes to share capital or management. As this is a general corporate announcement regarding a name change and does not fit into specific categories like M&A, financial reporting, or director dealings, it falls under the 'Regulatory Filings' (RNS) category as a general corporate disclosure.
2026-01-27 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a proposed corporate name change and rebranding strategy for Predictmedix AI Inc. It does not fit into specific financial reporting categories like 10-K, IR, or ER. As it is a general corporate announcement regarding business strategy and rebranding that does not fall into a more specific category, it is classified as a Regulatory Filing (RNS).
2026-01-12 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a 'Form 52-109FV2', which is a standard Canadian regulatory filing known as a 'Venture Issuer Basic Certificate'. This document serves as a formal certification by the CEO regarding the accuracy and fair presentation of the company's interim financial filings. Since it is a regulatory certification document required by securities legislation and does not fit into the specific categories of financial reports, management discussions, or announcements, it is best classified as a Regulatory Filing (RNS).
2025-12-20 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a 'Certification of Interim Filings' (Form 52-109FV2). According to the Certification Rule, documents that are primarily officer certifications or attestations, even if they reference a specific report type (like interim filings), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial data. Q3 2025
2025-12-20 English
Interim MD&A - English.pdf
Management Reports Classification · 100% confidence The document is explicitly titled 'MANAGEMENT DISCUSSION AND ANALYSIS' (MD&A) for Predictmedix AI Inc. It covers the three and nine months ended October 31, 2025. It provides a detailed narrative explanation of the company's business, products, operations, and forward-looking statements, which is the standard content for an MD&A report. This document is a core financial management report rather than a simple announcement or a full annual report.
2025-12-20 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.